How to Switch From Brello Health to PlexusDx Without Missing a Dose

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

You can switch from Brello Health to PlexusDx by starting your PlexusDx intake 10–14 days before your Brello supply runs out, allowing time for provider approval, prescription fulfillment, and shipping. Brello charges $399 every three months for compounded semaglutide (a prepaid per-month equivalent of $133) and $499 every 11 weeks for compounded tirzepatide (approximately $197/month on a recurring prepay schedule); PlexusDx charges $189/month for semaglutide and $289/month for tirzepatide on a month-to-month basis, or $169/month and $269/month respectively on a three-month plan. Brello's prepaid structure delivers a lower annual cost—$1,596 vs. $2,028 for semaglutide over 12 months, and $2,360 vs. $3,228 for tirzepatide—but PlexusDx offers month-to-month billing, the same price at every dose, and a 4.3-star Trustpilot rating with 83% of reviews at four stars or higher (captured September 9, 2026). The switching process centers on timing your intake, confirming your last Brello dose date, requesting medical records if available, and coordinating your first PlexusDx shipment to arrive before you run out.

At-a-glance comparison

Brello Health data captured September 4, 2026 from https://www.brellohealth.com/home1 and https://tirzepatidewoo.brellohealth.com/; PlexusDx data captured September 7, 2026.

Normalized 12-month cost comparison

Brello Health's prepaid block structure produces a lower annual outlay than PlexusDx's month-to-month pricing, though the gap narrows when you compare Brello's prepaid bundles to PlexusDx's three-month plan. All figures below are our calculations from verified pricing; confirm final costs at each provider's checkout.

Semaglutide injection (12 months)

• Brello Health: $399 every 3 months = $399 × 4 = $1,596/year (prepaid per-month equivalent $133)
• PlexusDx three-month plan: $169/month × 12 = $2,028/year
• PlexusDx month-to-month: $189/month × 12 = $2,268/year
• Difference: Brello is $432 less expensive than PlexusDx three-month and $672 less than month-to-month over 12 months.

Tirzepatide injection (12 months)

• Brello Health: $499 every 11 weeks = 4.73 cycles/year × $499 ≈ $2,360/year (approximately $197/month on a recurring prepay schedule)
• PlexusDx three-month plan: $269/month × 12 = $3,228/year
• PlexusDx month-to-month: $289/month × 12 = $3,468/year
• Difference: Brello is $868 less expensive than PlexusDx three-month and $1,108 less than month-to-month over 12 months.

Note on Brello's billing cycles: Semaglutide requires a three-month minimum commitment; confirm at Brello checkout whether the plan auto-renews or requires manual reorder. Tirzepatide rebills every 11 weeks and you may cancel anytime.

Step-by-step switching process

1. Identify your last Brello dose date

Check your Brello account or shipping confirmation to calculate when your current supply runs out. Semaglutide is typically dosed weekly; tirzepatide is also weekly. Count the number of doses remaining and mark the date of your final injection.

2. Start your PlexusDx intake 10–14 days early

Submit your PlexusDx intake questionnaire at least 10 days before your Brello supply ends. A licensed clinician will review your medical history, current dose, and weight-management goals. Provider review usually completes within 24–48 hours on business days, but starting early protects against approval delays, weekend gaps, or clarification requests.

3. Share your current dose and medical records (if available)

The PlexusDx intake form asks for your current medication and dose. Providing your Brello dose helps the clinician determine an appropriate starting point; the clinician may continue the same dose or adjust based on clinical judgment. If you have access to recent labs or a summary of care from Brello, upload or mention them in the intake—though most telehealth platforms do not automatically transfer records, and requesting them from Brello may add time you don't have during a switch.

4. Confirm approval and prescription fulfillment

Once the PlexusDx provider approves your prescription, the pharmacy begins compounding and shipping. Standard shipping typically takes 5–7 business days; check your account for tracking. If your Brello supply will run out before the PlexusDx shipment arrives, contact PlexusDx support to request expedited shipping (availability and cost vary).

5. Coordinate your first PlexusDx dose

Plan your first PlexusDx injection for the week after your last Brello dose. If both medications are the same compound (semaglutide or tirzepatide) and the same dose, you maintain weekly continuity. If the PlexusDx clinician prescribes a different dose, follow the provider's titration guidance exactly—never self-adjust to avoid a gap.

6. Cancel or pause your Brello subscription

Brello's tirzepatide plan rebills every 11 weeks and may be canceled anytime; log in to your account or contact Brello support before the next billing date. Semaglutide requires a three-month minimum, and the renewal behavior is not fully specified in available documentation—confirm at Brello checkout whether you need to cancel, pause, or simply let the plan lapse after the minimum term. Canceling before your final shipment may forfeit remaining doses, so time the cancellation for after your last vial arrives.

Decision factors unique to switching

Cost: Brello's prepaid advantage vs. PlexusDx's billing flexibility

Brello's three-month semaglutide block ($399) and 11-week tirzepatide cycle ($499) require upfront payment and deliver a lower annual cost than PlexusDx's month-to-month plans. If you are confident in 12-month continuation and prefer to minimize total spend, Brello's structure wins on price. PlexusDx's month-to-month option ($189 semaglutide, $289 tirzepatide) costs more annually but eliminates prepayment risk if your dose changes, side effects emerge, or you reach goal weight mid-year.

Dose consistency and pricing

PlexusDx charges the same monthly price at every dose of semaglutide or tirzepatide; whether you remain at 0.25 mg or titrate to 2.4 mg semaglutide, the cost stays $189/month (month-to-month) or $169/month (three-month plan). Brello's dose-pricing policy is not specified in available documentation; confirm at checkout whether the $399 or $499 figure applies at all doses or adjusts as you titrate.

Service track record

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026). We did not locate verified rating or review-volume data for Brello Health during this research pass; a Trustpilot profile exists but no attributable themes or star average were captured. If service responsiveness, fulfillment reliability, and customer-support quality matter to your switching decision, the available evidence favors PlexusDx.

Medication continuity and supply-chain considerations

Both Brello Health and PlexusDx dispense compounded semaglutide and tirzepatide through outsourced compounding pharmacies. Neither provider publishes the names of its partner pharmacies in customer-facing documentation. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. During a national shortage or supply disruption, any telehealth provider may experience fulfillment delays; starting your intake early and maintaining a few days' buffer protects against gaps regardless of which service you choose.

Choose Brello Health if…

• You are certain you will continue GLP-1 therapy for at least three months (semaglutide) or 11 weeks (tirzepatide) and want the lowest annual cost.
• You prefer to prepay in blocks and avoid monthly billing cycles.
• Your dose is stable, you tolerate the medication well, and you do not anticipate needing to pause or cancel mid-cycle.
• You do not require a verified service track record and are comfortable with the prepayment commitment.

Choose PlexusDx if…

• You want month-to-month billing flexibility and the ability to cancel without forfeiting a prepaid block.
• You value transparent, dose-invariant pricing—the same monthly cost whether you are at starting dose or maintenance dose.
• You prefer a provider with a verified Trustpilot rating (4.3 stars, 83% four stars or higher as of September 2026).
• You expect to titrate, adjust, or pause therapy during the next 12 months and want to avoid prepayment risk.
• You want access to multi-month discount plans (three-month or six-month) without mandatory prepayment of the full period upfront (PlexusDx three-month and six-month plans bill monthly at the discounted rate).

Timing strategies to avoid a dose gap

The most common switching failure is a dose gap caused by overlapping lead times. Use this timeline to protect continuity:

• Day 0: You have 14–21 days of Brello medication remaining (two to three weekly doses).
• Day 1: Complete your PlexusDx intake. Mark your anticipated final Brello dose date in the intake notes.
• Day 2–3: PlexusDx provider reviews and approves (typical case; allow up to 48 business hours).
• Day 3–4: Prescription sent to compounding pharmacy; compounding and packaging begin.
• Day 8–10: Shipment arrives (5–7 business days standard ground). You still have one Brello dose remaining.
• Day 14: Administer final Brello dose.
• Day 21: Administer first PlexusDx dose, maintaining weekly continuity.

If your Brello supply runs out before PlexusDx shipment arrives, contact PlexusDx support immediately to request expedited shipping or discuss bridging options. Do not skip a week and then double-dose; do not borrow medication from another person's prescription. If a gap occurs despite planning, resume at your prior dose once the new supply arrives and inform the prescribing clinician.

Clinical handoff: what the new provider needs to know

A smooth switch requires the PlexusDx clinician to understand your current therapy. Provide the following in your intake or during the provider consultation:

• Current medication and dose: "Compounded semaglutide 1.0 mg subcutaneous weekly" or "Compounded tirzepatide 7.5 mg subcutaneous weekly."
• Duration on current dose: How many weeks or months you have been at this dose without titration.
• Tolerability and side effects: Nausea, constipation, injection-site reactions, or other adverse effects you have experienced.
• Weight-loss progress: Pounds lost since starting GLP-1 therapy and whether your progress has plateaued.
• Reason for switching: Cost, billing flexibility, service experience, or other factors.

The PlexusDx clinician may continue your current dose, reduce it if you report persistent side effects, or recommend titration if you have plateaued. The clinician is not bound by your prior prescription and will prescribe based on current clinical appropriateness.

What happens to your Brello medical records?

Brello Health, like most telehealth platforms, maintains your consultation notes, prescription history, and intake questionnaire in its electronic health record system. Under HIPAA, you have the right to request a copy of your records; contact Brello support or check your account portal for a records-request form. Processing time varies—some platforms fulfill requests within a few business days, others take up to 30 days as permitted by law.

In practice, most patients switching between GLP-1 telehealth providers do not transfer formal medical records; instead, they self-report their current dose, duration, and side effects in the new intake form. If you have recent lab work (comprehensive metabolic panel, lipid panel, hemoglobin A1C) or imaging studies relevant to your weight-management plan, bringing those results to the PlexusDx consultation can inform the clinician's decision, but they are not required to start therapy.

Methodology and freshness

Brello Health pricing, billing cycles, and contract terms were captured September 4, 2026 from the provider's primary website (https://www.brellohealth.com/home1) and tirzepatide product page (https://tirzepatidewoo.brellohealth.com/). PlexusDx pricing and policies were captured September 7, 2026. Twelve-month cost figures are our calculations from verified per-period rates; prepaid per-month equivalents for Brello (semaglutide $133, tirzepatide $197) represent arithmetic division of bundle prices and are labeled as such. PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four stars or higher) was captured September 9, 2026. No verified rating or attributable review themes for Brello Health were captured in this research pass. Readers should confirm current pricing, billing cycles, cancellation policies, and shipping times at each provider's checkout before committing.

Frequently Asked Questions

Can I transfer my exact Brello dose to PlexusDx without restarting titration?

In most cases, yes. If you report your current Brello dose in the PlexusDx intake and tolerate it well, the PlexusDx clinician will typically continue that dose. However, the clinician may adjust based on side effects, weight-loss trajectory, or clinical guidelines, and the final decision rests with the prescribing provider.

How long does PlexusDx provider review and approval take?

Provider review typically completes within 24 to 48 hours on business days. Intakes submitted late Friday may not be reviewed until Monday. If the clinician requests clarification or additional information, approval may take an extra day. Starting your intake 10–14 days before your Brello supply ends protects against delays.

Will I pay twice in the same month if I switch mid-cycle?

Possibly. If you prepay Brello for three months or 11 weeks and start PlexusDx before that period ends, you will have paid both providers. To minimize overlap cost, time your switch so your first PlexusDx charge occurs after your Brello prepaid period expires, but prioritize medication continuity over billing efficiency.

Does PlexusDx charge the same price at every semaglutide or tirzepatide dose?

Yes. PlexusDx charges $189/month (month-to-month) or $169/month (three-month plan) for semaglutide injection at any dose, and $289/month (month-to-month) or $269/month (three-month plan) for tirzepatide injection at any dose. Dose adjustments do not change your monthly cost.

What if my PlexusDx shipment is delayed and I run out of Brello medication?

Contact PlexusDx support immediately to request expedited shipping if available. Do not skip a dose and then double up the following week. If a gap occurs, resume your prior dose once the shipment arrives and inform your clinician. In rare cases, your primary-care provider may be willing to bridge you with a short-term prescription, though insurance may not cover compounded GLP-1 medications.

Sources

• PlexusDx semaglutide and tirzepatide injection pricing and policies, accessed September 7, 2026
• Brello Health commercial terms summary (semaglutide and tirzepatide), accessed September 4, 2026
• Brello Health pricing: https://www.brellohealth.com/home1 and https://tirzepatidewoo.brellohealth.com/, accessed September 4, 2026
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four stars or higher), captured September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.